MyMD Pharmaceuticals® was issued a U.S. patent for treating cancers and other disorders associated with chronic inflammation by the United States Patent & Trademark Office (USPTO).
MyMD Pharmaceuticals® was issued a U.S. patent for treating cancers and other disorders associated with chronic inflammation by the United States Patent & Trademark Office (USPTO).